SLC17A3
Basic information
Region (hg38): 6:25833066-25882286
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC17A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 2 | 4 |
Variants in SLC17A3
This is a list of pathogenic ClinVar variants found in the SLC17A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-25845389-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
6-25845389-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
6-25845390-G-A | not specified | Uncertain significance (Jun 07, 2024) | ||
6-25845396-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
6-25845410-G-A | not specified | Uncertain significance (May 26, 2022) | ||
6-25845472-G-A | SLC17A3-related disorder | Benign (Mar 18, 2019) | ||
6-25845498-T-A | not specified | Uncertain significance (Dec 22, 2023) | ||
6-25849417-G-C | not specified | Uncertain significance (Dec 20, 2023) | ||
6-25849420-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
6-25849462-T-C | not specified | Uncertain significance (Jul 14, 2021) | ||
6-25849847-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
6-25849853-G-A | not specified | Uncertain significance (Jun 11, 2021) | ||
6-25849866-A-T | SLC17A3-related disorder | Benign (Aug 01, 2019) | ||
6-25849936-T-C | SLC17A3-related disorder | Benign (Jul 15, 2020) | ||
6-25850541-A-G | Uric acid concentration, serum, quantitative trait locus 4 | association (Nov 05, 2010) | ||
6-25850599-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
6-25850617-C-T | SLC17A3-related disorder | Benign (Nov 26, 2019) | ||
6-25850620-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
6-25850827-C-T | not specified | Uncertain significance (Jul 12, 2022) | ||
6-25855230-C-T | not specified | Uncertain significance (Nov 22, 2022) | ||
6-25861672-A-C | not specified | Uncertain significance (Jan 09, 2024) | ||
6-25862321-G-A | not specified | Uncertain significance (Sep 13, 2023) | ||
6-25862323-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
6-25862334-T-G | Uric acid concentration, serum, quantitative trait locus 4 | risk factor (Nov 05, 2010) | ||
6-25862348-A-G | not specified | Uncertain significance (Mar 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC17A3 | protein_coding | protein_coding | ENST00000397060 | 11 | 49221 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.93e-22 | 0.000368 | 125611 | 0 | 137 | 125748 | 0.000545 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.298 | 272 | 259 | 1.05 | 0.0000127 | 3200 |
Missense in Polyphen | 68 | 63.467 | 1.0714 | 835 | ||
Synonymous | -0.0527 | 94 | 93.4 | 1.01 | 0.00000477 | 1023 |
Loss of Function | -0.489 | 31 | 28.2 | 1.10 | 0.00000157 | 309 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00146 | 0.00143 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000465 | 0.0000462 |
European (Non-Finnish) | 0.000538 | 0.000536 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.000954 | 0.000948 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Isoform 2: voltage-driven, multispecific, organic anion transporter able to transport para-aminohippurate (PAH), estrone sulfate, estradiol-17-beta-glucuronide, bumetanide, and ochratoxin A. Isoform 2 functions as urate efflux transporter on the apical side of renal proximal tubule and is likely to act as an exit path for organic anionic drugs as well as urate in vivo. May be involved in actively transporting phosphate into cells via Na(+) cotransport.;
- Pathway
- Uricosurics Pathway, Pharmacodynamics;Stimuli-sensing channels;Ion channel transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.0945
Intolerance Scores
- loftool
- 0.983
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62
Haploinsufficiency Scores
- pHI
- 0.0884
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.383
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0557
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc17a3
- Phenotype
Gene ontology
- Biological process
- sodium ion transport;phosphate ion transport;drug transmembrane transport;organic anion transport;sialic acid transport;urate transport;glucose-6-phosphate transport;drug transport;ion transmembrane transport;sodium ion transmembrane transport;urate metabolic process;toxin transport
- Cellular component
- cytoplasm;lysosome;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;integral component of membrane;apical plasma membrane;brush border membrane;perinuclear region of cytoplasm
- Molecular function
- sodium:phosphate symporter activity;voltage-gated anion channel activity;organic anion transmembrane transporter activity;sialic acid transmembrane transporter activity;urate transmembrane transporter activity;drug transmembrane transporter activity;efflux transmembrane transporter activity;toxin transmembrane transporter activity